CombiMatrix Stock Hits 52-Week High | GenomeWeb
NEW YORK (GenomeWeb News) – Shares of CombiMatrix closed at a 52-week high of $13.31 on Wednesday.
Over the past two weeks, shares of the Mukilteo, Wash.-based microarray manufacturer and molecular diagnostics firm have climbed around 20 percent. Year to date, the company’s stock is up nearly 80 percent.
Last week, CombiMatrix reported that its second-quarter revenues jumped 55 percent to $2.1 million, driven by diagnostic services revenue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.